Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience.
Immunotherapy
; 11(11): 945-952, 2019 08.
Article
en En
| MEDLINE
| ID: mdl-31199183
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Carcinoma de Pulmón de Células no Pequeñas
/
Nivolumab
/
Neoplasias Pulmonares
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2019
Tipo del documento:
Article